| Dr Tonya Marie Kratovil, MD | |
|
1301 Punchbowl St, Honolulu, HI 96813-2499 | |
| (808) 294-3961 | |
| Not Available |
| Full Name | Dr Tonya Marie Kratovil |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1301 Punchbowl St, Honolulu, Hawaii |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598701476 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 19387 (Hawaii) | Primary |
| 2080P0207X | Pediatrics - Pediatric Hematology-oncology | 19387 (Hawaii) | Secondary |
| Entity Name | The Queens Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487693586 PECOS PAC ID: 3476454067 Enrollment ID: O20040116000366 |
News Archive
Obesity is probably the most important factor in the development of insulin resistance, but science's understanding of the chain of events is still spotty. Now, researchers at the Salk Institute for Biological Studies have filled in the gap and identified the missing link between the two.
Removing race as a factor in a kidney function-estimating equation used to guide cancer treatment dosing and eligibility may decrease the proportion of Black patients recommended to receive full doses of anticancer drugs.
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has accepted TxCell's Investigational New Drug application for the company's lead product, Ovasave(R), currently in a phase 2b clinical trial for the treatment of patients with refractory Crohn's disease.
In a study of 1,721 Korean male drinkers aged 40 y in an urban population-based cohort, and another sample of 1,113 male drinkers from an independent rural cohort, information on average daily alcohol consumption was collected and DNA samples were collected for genotyping.
A bill passed last month by the House that would require the HHS secretary to negotiate prices directly with pharmaceutical companies under the Medicare prescription drug benefit "would have very little effect" on prices "because it forbids Medicare from excluding drugs from coverage...
› Verified 9 days ago
| Entity Name | Queen's North Hawaii Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528049814 PECOS PAC ID: 0143116293 Enrollment ID: O20040225000562 |
News Archive
Obesity is probably the most important factor in the development of insulin resistance, but science's understanding of the chain of events is still spotty. Now, researchers at the Salk Institute for Biological Studies have filled in the gap and identified the missing link between the two.
Removing race as a factor in a kidney function-estimating equation used to guide cancer treatment dosing and eligibility may decrease the proportion of Black patients recommended to receive full doses of anticancer drugs.
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has accepted TxCell's Investigational New Drug application for the company's lead product, Ovasave(R), currently in a phase 2b clinical trial for the treatment of patients with refractory Crohn's disease.
In a study of 1,721 Korean male drinkers aged 40 y in an urban population-based cohort, and another sample of 1,113 male drinkers from an independent rural cohort, information on average daily alcohol consumption was collected and DNA samples were collected for genotyping.
A bill passed last month by the House that would require the HHS secretary to negotiate prices directly with pharmaceutical companies under the Medicare prescription drug benefit "would have very little effect" on prices "because it forbids Medicare from excluding drugs from coverage...
› Verified 9 days ago
| Entity Name | Queens University Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891441382 PECOS PAC ID: 2466831557 Enrollment ID: O20220621000534 |
News Archive
Obesity is probably the most important factor in the development of insulin resistance, but science's understanding of the chain of events is still spotty. Now, researchers at the Salk Institute for Biological Studies have filled in the gap and identified the missing link between the two.
Removing race as a factor in a kidney function-estimating equation used to guide cancer treatment dosing and eligibility may decrease the proportion of Black patients recommended to receive full doses of anticancer drugs.
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has accepted TxCell's Investigational New Drug application for the company's lead product, Ovasave(R), currently in a phase 2b clinical trial for the treatment of patients with refractory Crohn's disease.
In a study of 1,721 Korean male drinkers aged 40 y in an urban population-based cohort, and another sample of 1,113 male drinkers from an independent rural cohort, information on average daily alcohol consumption was collected and DNA samples were collected for genotyping.
A bill passed last month by the House that would require the HHS secretary to negotiate prices directly with pharmaceutical companies under the Medicare prescription drug benefit "would have very little effect" on prices "because it forbids Medicare from excluding drugs from coverage...
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tonya Marie Kratovil, MD 1301 Punchbowl St, Honolulu, HI 96813-2499 Ph: (808) 294-3961 | Dr Tonya Marie Kratovil, MD 1301 Punchbowl St, Honolulu, HI 96813-2499 Ph: (808) 294-3961 |
News Archive
Obesity is probably the most important factor in the development of insulin resistance, but science's understanding of the chain of events is still spotty. Now, researchers at the Salk Institute for Biological Studies have filled in the gap and identified the missing link between the two.
Removing race as a factor in a kidney function-estimating equation used to guide cancer treatment dosing and eligibility may decrease the proportion of Black patients recommended to receive full doses of anticancer drugs.
TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells for severe chronic inflammatory and autoimmune diseases, announces today that the United States Food and Drug Administration has accepted TxCell's Investigational New Drug application for the company's lead product, Ovasave(R), currently in a phase 2b clinical trial for the treatment of patients with refractory Crohn's disease.
In a study of 1,721 Korean male drinkers aged 40 y in an urban population-based cohort, and another sample of 1,113 male drinkers from an independent rural cohort, information on average daily alcohol consumption was collected and DNA samples were collected for genotyping.
A bill passed last month by the House that would require the HHS secretary to negotiate prices directly with pharmaceutical companies under the Medicare prescription drug benefit "would have very little effect" on prices "because it forbids Medicare from excluding drugs from coverage...
› Verified 9 days ago
Dr. Patricia Louise Heu, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 741 Sunset Ave, Honolulu, HI 96816 Phone: 808-733-9058 Fax: 808-733-9068 | |
Marissa Helene Fakaosita, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1319 Punahou St Fl 7, Honolulu, HI 96826 Phone: 808-369-1200 | |
Dr. Jeffrey K. Okamoto, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1319 Punahou St, Suite 757, Honolulu, HI 96826 Phone: 808-983-8387 Fax: 808-945-1570 | |
Eliot Nobuo Tomomitsu, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 321 N Kuakini St, Suite #201, Honolulu, HI 96817 Phone: 808-523-8611 | |
James A Griffith, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Marivic Cristobal Raymundo, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 915 N King St, Honolulu, HI 96817 Phone: 808-848-1438 | |
Kelley Chinen Okimoto, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1319 Punahou St, Honolulu, HI 96826 Phone: 808-983-8387 |